

Rosemary Senguttuvan, MD
NOTE : If you're an existing patient, please connect via MyChart
-
About Me
About Rosemary Senguttuvan, MD
Rosemary Senguttuvan, MD, is a board-certified obstetrician-gynecologist specializing in the surgical and medical treatment of ovarian, uterine, vaginal, vulvar and cervical cancers. She is a member of the American Society of Clinical Oncology, the Society of Gynecologic Oncology, the International Gynecologic Cancer Society, the Arnold P. Gold Foundation, the Gold Humanism Honor Society, the American Medical Association and the Texas Medical Association.
Dr. Senguttuvan graduated from The University of Texas at San Antonio and earned her medical degree from the University of Texas Medical Branch. She completed her residency in obstetrics and gynecology at the same institution, followed by a fellowship in gynecologic oncology at City of Hope Comprehensive Cancer Center.
Her clinical practice focuses on the comprehensive care of patients with gynecologic cancers, integrating advanced surgical techniques with personalized medical therapies. She has specialty training in heated intraperitoneal chemotherapy. Her research interests include developing novel therapeutics for targeted ovarian cancer treatment and expanding access to clinical trials for women with gynecologic cancers.
In her free time, she enjoys painting, reading, baking and spending time with her family.
Gender
- Female
Languages Spoken
- English
- French
-
Credentials
Credentials
Positions
- Assistant Professor, Division of Gynecologic Oncology, University of Texas Health Science Center San Antonio
- Gynecologic Oncologist, UT Health San Antonio MD Anderson Cancer Center
Certifications
- American Board of Obstetrics & Gynecology, Obstetrics and Gynecology
Education
Medical School: The University of Texas Medical Branch, Galveston, Texas
Fellowship: Gynecologic Oncology, City of Hope Comprehensive Cancer Center, Duarte, California
Residency: Obstetrics and Gynecology, The University of Texas Medical Branch, Galveston, Texas
Undergraduate: The University of Texas at San Antonio, San Antonio, Texas
-
Locations & Contact
Locations & Contact
-
Research & Publications
Research & Publications
A Critical Role of Intracellular PD-L1 in Promoting Ovarian Cancer Progression
Huang R*, Nakamura B* , Senguttuvan R*, Li YJ, Martincuks A, Bakkar R, Song M, Ann DK, Rodriguez-Rodriguez L, Yu H.
Cells. 2025 Feb 19;14(4):314. doi: 10.3390/cells14040314. PMID: 39996786; PMCID: PMC11853747. (*co-first authorship)
Pressurized intraperitoneal aerosolized chemotherapy (PIPAC) experience in patients with recurrent low grade serous ovarian carcinoma (LGSOC): sub-cohort report of phase 1 clinical trial
Nakamura B, Senguttuvan R, Ruel NH, Frankel PH, Yost SE, Cole S, Chang S, Jung A, Eng M, Tinsley R, Stewart D, Wang E, Cohen J, Villella J, Whelan RL, Merchea A, DePeralta DK, Cristea M, Wakabayashi MT, Raoof M, Dellinger TH.
Front Oncol. 2024 Aug 1;14:1404936. doi: 10.3389/fonc.2024.1404936. PMID: 39148906; PMCID: PMC11324501.
Uterine cancer restaging according to the updated 2023 FIGO Guidelines does not uniformly affect prognosis: An institutional retrospective cohort study
Senguttuvan RN, Lugo Santiago N, Nakamura B, Song M, Han ES, Ruel N, Cook D, Robinson K, Kohut A, Cohen JG.
Gynecologic Oncology, 189, 41–48. Epub 2024 Jul 14. https://doi.org/10.1016/j.ygyno.2024.06.024. PMID: 39003960
View All Publications - Rosemary Senguttuvan
-
Clinical Trials
Clinical Trials
No Clinical Trials